PRESS RELEASE published on 12/16/2024 at 07:00, 1 year 10 months ago Andrea Kleiner appointed Head of Business Clients at Baloise Andrea Kleiner appointed Head of Business Clients at Baloise. With a background in insurance and extensive managerial experience, she will join Baloise's Executive Committee in Switzerland on 1 April 2025 Insurance Executive Committee Baloise Business Clients Andrea Kleiner
BRIEF published on 12/09/2024 at 07:05, 1 year 10 months ago Changes in the Board of Directors of Baloise Holding Ltd. Board Of Directors Insurance Appointments Financial Markets Baloise Holding
PRESS RELEASE published on 12/09/2024 at 07:00, 1 year 10 months ago Changes to the Board of Directors of Baloise Holding Ltd Changes to the Board of Directors announced at the 2025 Annual General Meeting of Baloise Holding Ltd to enhance insurance and financial market expertise Board Of Directors Annual General Meeting Insurance Financial Markets Baloise Holding Ltd
BRIEF published on 11/27/2024 at 09:05, 1 year 11 months ago Travel and family, life priorities of the Swiss according to Baloise Financial Security Life Goals Swiss Population Travel And Family Risk Appetite
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 11 months ago Travel, family and financial security: the top life goals of the Swiss Swiss people set travel, family, and financial security as top life goals. Baloise survey reveals insights on risk, inspiration sources, goal achievement, and financial planning Financial Planning Swiss Life Goals Risk Appetite Baloise Survey
BRIEF published on 11/26/2024 at 09:05, 1 year 11 months ago Charles Ischi AG Wins InnoPrix SO! Award for Pharmaceutical Innovation Pharmaceutical Innovation Charles Ischi AG DISI Evo Tester InnoPrix SO! Solothurn Region
PRESS RELEASE published on 11/26/2024 at 09:00, 1 year 11 months ago Charles Ischi AG wins the 2024 InnoPrix SO! award for its innovative pharmaceutical tester Charles Ischi AG wins the 2024 InnoPrix SO! award for its innovative pharmaceutical tester, the DISI Evo, revolutionizing medication disintegration time measurement Charles Ischi AG InnoPrix SO! Pharmaceutical Tester DISI Evo Medication Disintegration
BRIEF published on 11/20/2024 at 07:05, 1 year 11 months ago Baloise Projects CHF 550 Million Cash Remittance Amid Refocusing Strategy Strategy Baloise Cash Remittance Insurance Growth Capital Base
BRIEF published on 11/20/2024 at 07:05, 1 year 11 months ago Baloise Implements Refocusing Strategy Amid Financial Adjustments Share Buy-back Cash Remittance SST Ratio Non-life Growth Baloise Strategy
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 11 months ago Baloise is implementing its refocusing strategy – cash remittance of over CHF 550 million expected Baloise Holding AG implements refocusing strategy with CHF 550 million cash remittance expected. First milestones reached, solid financial targets set Business Growth Financial Targets Baloise Refocusing Strategy Cash Remittance
Published on 11/06/2026 at 22:15, 17 hours 27 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 2 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 3 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 3 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 2 hours 7 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 19 hours 27 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 20 hours 27 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 20 hours 42 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 21 hours 10 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 21 hours 42 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 21 hours 48 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 22 hours 7 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
